Tryptophan Depletion Causes a Rapid Lowering of Mood in Normal Males

Overview

Journal Psychopharmacology (Berl)

Specialty Pharmacology

Date 1985 Jan 1

PMID 3931142

Citations 156

Authors

S N Young

S E Smith

R O Pihl

F R Ervin

Affiliations

Soon will be listed here.

Abstract

Normal male human subjects ingested amino acid mixtures which were tryptophan-free, balanced or contained excess tryptophan. The tryptophan-free mixture causes a marked depletion of plasma tryptophan by 5 h. At this time the subjects in the tryptophan-free group had significantly elevated scores on the depression scale of the Multiple Affect Adjective Checklist. The tryptophan-free group also performed worse than the other two groups in a proofreading task carried out while listening to a tape with themes of hopelessness and helplessness (dysphoric distractor). Cognitive theories of depression predict greater distractability of depressed individuals by dysphoric themes. Thus, both measures indicate a rapid mood lowering effect of tryptophan depletion in normal males. This effect is probably mediated by a lowering of brain 5-hydroxytryptamine. Although the mood-lowering effect was not as great as that seen in depressed patients, our results suggest that low brain 5HT might be one factor precipitating depression in some patients.

Citing Articles

Dietary supplement for mood symptoms in early postpartum: a double-blind randomized placebo controlled trial.

Meyer J, Wang Z, Santhirakumar A, Dowlati Y, Docteur N, Shoaib A EClinicalMedicine. 2024; 71:102593.

PMID: 38813444 PMC: 11133796. DOI: 10.1016/j.eclinm.2024.102593.

Arbitration between model-free and model-based control is not affected by transient changes in tonic serotonin levels.

Gilger M, Hellrung L, Neukam P, Kroemer N, Nebe S, Pooseh S J Psychopharmacol. 2023; 38(2):178-187.

PMID: 38151862 PMC: 10863371. DOI: 10.1177/02698811231216325.

Effect of Leflunomide-Metal Complexes on ROS, TNF, and Brain Indolamines in Comparison with Anti-Depressants as Adjunct Therapy in Rheumatoid Arthritic Model.

Naeem A, Jahan N, Mehboob Khan M, Abbas G, Siddiqui F, Khalid M Biomedicines. 2023; 11(8).

PMID: 37626711 PMC: 10452628. DOI: 10.3390/biomedicines11082214.

Beneficial Effect of Increased Tryptophan Intake on Its Metabolism and Mental State of the Elderly.

Chojnacki C, Gasiorowska A, Poplawski T, Konrad P, Chojnacki M, Fila M Nutrients. 2023; 15(4).

PMID: 36839204 PMC: 9961537. DOI: 10.3390/nu15040847.

Temporal derivative computation in the dorsal raphe network revealed by an experimentally driven augmented integrate-and-fire modeling framework.

Harkin E, Lynn M, Payeur A, Boucher J, Caya-Bissonnette L, Cyr D Elife. 2023; 12.

PMID: 36655738 PMC: 9977298. DOI: 10.7554/eLife.72951.

References

Smith B, Prockop D . Central-nervous-system effects of ingestion of L-tryptophan by normal subjects. N Engl J Med. 1962; 267:1338-41. DOI: 10.1056/NEJM196212272672603. View

Shopsin B, Friedman E, Gershon S . Parachlorophenylalanine reversal of tranylcypromine effects in depressed patients. Arch Gen Psychiatry. 1976; 33(7):811-9. DOI: 10.1001/archpsyc.1976.01770070041003. View

van Praag H, de Haan S . Central serotonin metabolism and frequency of depression. Psychiatry Res. 1979; 1(3):219-24. DOI: 10.1016/0165-1781(79)90002-7. View

Greenwood M, Lader M, Kantameneni B, Curzon G . The acute effects of oral (--)-tryptophan in human subjects. Br J Clin Pharmacol. 1975; 2(2):165-72. PMC: 1402514. DOI: 10.1111/j.1365-2125.1975.tb01572.x. View

Traskman-Bendz L, Asberg M, Bertilsson L, Thoren P . CSF monoamine metabolites of depressed patients during illness and after recovery. Acta Psychiatr Scand. 1984; 69(4):333-42. DOI: 10.1111/j.1600-0447.1984.tb02503.x. View

Murphy D, Campbell I, Costa J . The brain serotonergic system in the affective disorders. Prog Neuropsychopharmacol. 1978; 2(1):5-31. DOI: 10.1016/0364-7722(78)90019-x. View

Cremata Jr V, KOE B . Clinical-pharmacological evaluation of p-chlorophenylalanine: a new serotonin-depleting agent. Clin Pharmacol Ther. 1966; 7(6):768-76. DOI: 10.1002/cpt196676768. View

Gessa G, Biggio G, Fadda F, Corsini G, Tagliamonte A . Effect of the oral administration of tryptophan-free amino acid mixtures on serum tryptophan, brain tryptophan and serotonin metabolism. J Neurochem. 1974; 22(5):869-70. DOI: 10.1111/j.1471-4159.1974.tb04308.x. View

Engelman K, Lovenberg W, SJOERDSMA A . Inhibition of serotonin synthesis by para-chlorophenylalanine in patients with the carcinoid syndrome. N Engl J Med. 1967; 277(21):1103-8. DOI: 10.1056/NEJM196711232772101. View

10.

Coppen A, Prange Jr A, Whybrow P, Noguera R . Abnormalities of indoleamines in affective disorders. Arch Gen Psychiatry. 1972; 26(5):474-8. DOI: 10.1001/archpsyc.1972.01750230084016. View

11.

Sedvall G, Fyro B, Gullberg B, Nyback H, Wiesel F . Relationships in healthy volunteers between concentrations of monoamine metabolites in cerebrospinal fluid and family history of psychiatric morbidity. Br J Psychiatry. 1980; 136:366-74. DOI: 10.1192/bjp.136.4.366. View

12.

Lapin I, Oxenkrug G . Intensification of the central serotoninergic processes as a possible determinant of the thymoleptic effect. Lancet. 1969; 1(7586):132-6. DOI: 10.1016/s0140-6736(69)91140-4. View

13.

Shopsin B, Gershon S, Goldstein M, Friedman E, Wilk S . Use of synthesis inhibitors in defining a role for biogenic amines during imipramine treatment in depressed patients. Psychopharmacol Commun. 1975; 1(2):239-49. View

14.

Biggio G, Fadda F, Fanni P, Tagliamonte A, Gessa G . Rapid depletion of serum tryptophan, brain tryptophan, serotonin and 5-hydroxyindoleacetic acid by a tryptophan-free diet. Life Sci. 1974; 14(7):1321-9. DOI: 10.1016/0024-3205(74)90440-8. View

15.

Goodwin F, Post R . 5-hydroxytryptamine and depression: a model for the interaction of normal variance with pathology. Br J Clin Pharmacol. 1983; 15 Suppl 3:393S-405S. PMC: 1427648. DOI: 10.1111/j.1365-2125.1983.tb02130.x. View

16.

Oldendorf W, Szabo J . Amino acid assignment to one of three blood-brain barrier amino acid carriers. Am J Physiol. 1976; 230(1):94-8. DOI: 10.1152/ajplegacy.1976.230.1.94. View

17.

MUNRO H . Role of amino acid supply in regulating ribosome function. Fed Proc. 1968; 27(5):1231-7. View

18.

Lieberman H, Corkin S, Spring B, Growdon J, Wurtman R . Mood, performance, and pain sensitivity: changes induced by food constituents. J Psychiatr Res. 1982; 17(2):135-45. DOI: 10.1016/0022-3956(82)90015-2. View

19.

Coppen A . The biochemistry of affective disorders. Br J Psychiatry. 1967; 113(504):1237-64. DOI: 10.1192/bjp.113.504.1237. View

20.

Praag H . The Harold E. Himwich Memorial Lecture. Significance of biochemical parameters in the diagnosis, treatment, and prevention of depressive disorders. Biol Psychiatry. 1977; 12(1):101-31. View